Former GOP Speaker Pledges to Push Ibogaine Access to Save Lives

It is not every day you hear a former GOP House Speaker championing psychedelics, but Newt Gingrich is doing exactly that. He is throwing his political weight behind ibogaine, calling the substance a potential "breakthrough" for a "sick care system" that has failed those struggling with addiction and PTSD. Gingrich is joining a growing, bipartisan group of officials—including Robert F. Kennedy Jr. and VA Secretary Doug Collins—pushing for expanded research and veteran access to psychedelic therapies like psilocybin and MDMA. Bipartisan bills are already hitting the floor to fund specialized treatment centers within the VA.

For the cannabis community, this mainstreaming of plant medicine is a massive win. When heavy hitters in the "old guard" start recognizing the therapeutic value of once-taboo substances, it breaks down the stigma that has held back sensible drug policy for decades. For everyday tokers, this shift signals a future where natural alternatives are respected as legitimate medicine, potentially paving the way for easier access and more comprehensive federal reform across the board.